Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Felcisetrag

Generic Name: Felcisetrag

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₃₇N_₅O_₃

CAS Number: 916075-84-8

Unique Ingredient Identifier: 35F0Y2W16Q

Overview

Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder.

Background

Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants

Phase 1

Completed

Posted: 2019/03/12

Sponsor:Millennium Pharmaceu...

ID:NCT03870555

A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery

Phase 2

Completed

Posted: 2019/02/01

Sponsor:Takeda

ID:NCT03827655

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Phase 2

Terminated

Posted: 2018/03/27

Sponsor:Millennium Pharmaceu...

ID:NCT03477903

A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

Phase 1

Completed

Posted: 2017/09/28

Sponsor:Takeda

ID:NCT03296787

Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants

Phase 2

Completed

Posted: 2017/09/13

Sponsor:Takeda

ID:NCT03281577

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy